- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 2, 2024 | 8.22M sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $0 |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $303.95M |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $0 |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $6.27M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $112.76M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $87.3M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $1.26B |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.39B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.35B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.48B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $974.47M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $1.09B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.11B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.23B |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 7.89M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $1.86M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$615.02M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$339.99M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$200.49M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$23.68 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$23.68 |
| Net Income | Q1 2024 · Mar 31, 2023 | −$175.01M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$44.87M |